I'm not sure it will play out like that @danishcookie, but you've made the point well.
I think there are 2 very different ways to look at this.
1 - Is the way @tossydog and others have framed it. The NASDAQ move is the best and brightest, bigger markets that understand biotech, more $$ flowing in, great trial results, take-over offers in the AUD $$ multiples.
2 - The way @danishcookie and others see it. A rushed move to an exchange we will be manipulated on, stifled gains for aussie holders and a low take-over bid down the line.
Both views have their merit.
Either way you see it one thing is clear, if you bought IHL in the last 2/2.5 years you are either coming along for the ride or you're selling out on the ASX for a loss.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq
Ann: IHL Intends to Redomicile to US & List all Shares on Nasdaq, page-163
-
- There are more pages in this discussion • 393 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online